144 related articles for article (PubMed ID: 3966714)
1. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
Hilliker KS; Roth RA
Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
3. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
Hilliker KS; Bell TG; Roth RA
Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
[TBL] [Abstract][Full Text] [Related]
4. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
Ganey PE; Sprugel KH; Hadley KB; Roth RA
J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
[TBL] [Abstract][Full Text] [Related]
5. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
Gillespie MN; Olson JW; Reinsel CN; O'Connor WN; Altiere RJ
Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
[TBL] [Abstract][Full Text] [Related]
6. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
Hilliker KS; Bell TG; Lorimer D; Roth RA
Am J Physiol; 1984 Jun; 246(6 Pt 2):H747-53. PubMed ID: 6742140
[TBL] [Abstract][Full Text] [Related]
7. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
Hilliker KS; Garcia CM; Roth RA
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):179-97. PubMed ID: 6410470
[TBL] [Abstract][Full Text] [Related]
8. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
J Toxicol Environ Health; 1988; 23(1):127-37. PubMed ID: 3336057
[TBL] [Abstract][Full Text] [Related]
9. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
Exp Lung Res; 1987; 12(3):195-206. PubMed ID: 3107969
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
Ganey PE; Roth RA
Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
Ganey PE; Sprugel KH; White SM; Wagner JG; Roth RA
Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
[TBL] [Abstract][Full Text] [Related]
12. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
[TBL] [Abstract][Full Text] [Related]
13. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
Hilliker KS; Roth RA
Exp Lung Res; 1985; 8(4):201-12. PubMed ID: 4043006
[TBL] [Abstract][Full Text] [Related]
14. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
Bruner LH; Johnson KJ; Till GO; Roth RA
Am J Physiol; 1988 Feb; 254(2 Pt 2):H258-64. PubMed ID: 3344816
[TBL] [Abstract][Full Text] [Related]
15. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
Pan LC; Wilson DW; Segall HJ
Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
[TBL] [Abstract][Full Text] [Related]
16. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
White SM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
[TBL] [Abstract][Full Text] [Related]
17. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
Roth RA; Ganey PE
Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680
[TBL] [Abstract][Full Text] [Related]
18. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
Bruner LH; Bull RW; Roth RA
Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514
[TBL] [Abstract][Full Text] [Related]
19. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
20. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
Roth RA; Reindel JF
Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]